Results 321 to 330 of about 1,969,863 (367)

Engineering CAR‐T Therapeutics for Enhanced Solid Tumor Targeting

Advanced Materials, EarlyView.
CART cell therapy has proven effective for blood cancers but struggles with solid tumors due to diverse antigens and complex environments. Recent efforts focus on improving CAR design and validation platforms. Advances in protein engineering, machine learning, and organoid systems aim to enhance CAR‐T therapy against solid tumors.
Danqing Zhu, Won Joon Kim, Hyunjin Lee, Xiaoping Bao, Pilnam Kim   +4 more
wiley   +1 more source

Radiomic-based models are able to predict the pathologic response to different neoadjuvant chemotherapy regimens in patients with gastric and gastroesophageal cancer: a cohort study. [PDF]

World J Surg Oncol
Agnes A, Boldrini L, Perillo F, Tran HE, Brizi MG, Ricci R, Lenkowicz J, Votta C, Biondi A, Manfredi R, Valentini V, D'Ugo DM, Persiani R.   +12 more
europepmc   +1 more source

State‐of‐the‐Art, Insights, and Perspectives for MOFs‐Nanocomposites and MOF‐Derived (Nano)Materials

Advanced Materials, EarlyView.
Different approaches to MOF‐NP composite formation, such as ship‐in‐a‐bottle, bottle‐around‐the‐ship and in situ one‐step synthesis, are used. Owing to synergistic effects, the advantageous features of the components of the composites are beneficially combined, and their individual drawbacks are mitigated.
Stefanos Mourdikoudis, Subhajit Dutta, Saqib Kamal, Sergio Gómez‐Graña, Isabel Pastoriza‐Santos, Stefan Wuttke, Lakshminarayana Polavarapu   +6 more
wiley   +1 more source

Immunotherapy combined with chemotherapy: a promising therapeutic approach in the management of colonic squamous cell carcinoma-a case report. [PDF]

Front Oncol
Ren B, Yang H, Mao Y.
europepmc   +1 more source

Adherence to chemotherapy and associated factors among adult patients with cancer in the Amhara region, Ethiopia, 2022. [PDF]

Discov Oncol
Ademe S, Mohammed T, Edmealem A, Tegegne B, Bewket B, Andualem A, Bires A.   +6 more
europepmc   +1 more source

Treatment outcomes of dogs with transitional cell carcinoma. [PDF]

Front Vet Sci
Chu KT, Nekouei O, Giuliano A.
europepmc   +1 more source

Diagnostic performance of circulating EpCAM+ and CD45+ extracellular vesicles in platinum-sensitivity in high-grade serous ovarian cancer: a pilot study. [PDF]

J Ovarian Res
Tersigni C, Onori M, Buzzonetti A, Ferrante A, Fattorossi A, Battaglia A, Corrado G, Neri C, Beneduce G, Sannino F, Petrecca A, Scambia G, Fagotti A.   +12 more
europepmc   +1 more source

The BEV1L study: Do real-world outcomes associated with the addition of bevacizumab to first-line chemotherapy in patients with ovarian cancer reinforce clinical trial findings? [PDF]

Cancer
Duska LR, Lim J, Calderón Boyle TA, Guinter M, Halloran S, Hartman J, Schilder JM, Hurteau JA, Golembesky AK.   +8 more
europepmc   +1 more source

Consensus statements from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology on the management of muscle-invasive and advanced urothelial carcinoma. [PDF]

Front Oncol
Poon DMC, Chiu PKF, Chan MTY, Ho BSH, Law KS, Leung AKC, Leung CLH, Na R, Wong KCW, Wu PY, Kwong PWK, Teoh JYC.   +11 more
europepmc   +1 more source

Efficacy and safety of BCG and immune checkpoint inhibitors in non-muscle invasive bladder cancer: A meta-analysis with exploratory chemotherapy comparisons. [PDF]

Oncol Lett
Adan MM, Mao X, Ding L, Abdullahi KM, Li G.   +4 more
europepmc   +1 more source